Login

No Longer Reporting

The company has not filed an annual or quarterly report since its Q2 FY2022 10-Q, filed Aug 8, 2022. Its latest SEC filing is a SC 13G/A from Nov 8, 2022.

The sections below describe the company as of the FY2021 annual report.

What Did They Do?

Provides custom orthotic and prosthetic devices and related patient care to people with disabilities or injuries. Also distributes orthotic and prosthetic products and provides rehabilitation solutions to independent providers and post-acute care facilities.

How Did They Make Money?

Hanger bills insurers, government health programs and private-pay patients at or after device delivery; distributors pay for products when shipped or delivered, typically within 30 to 90 days. Rehabilitation equipment programs earn fees over the period customers use equipment or receive services, while equipment and consumables are sold at shipment.

FY2021 revenue

Who Were Their Customers?

Physicians refer patients to Hanger Clinic; Hanger bills insurers, government health programs or patients paying privately. Sales staff calls directly on independent orthotic and prosthetic providers and skilled nursing and post-acute care providers for products and rehabilitation solutions.

Did Revenues Turn Into Profits?

Yes. It kept 4 cents of every revenue dollar as net income in FY2021 and turned 1 cent into free cash flow.

Operating income, FY2021
6% of revenue
▲ +1% vs FY2020 ($71.9M, 7%)
Net income, FY2021
4% of revenue
▲ +10% vs FY2020 ($38.2M, 4%)
Free cash flow, FY2021
1% of revenue
▼ −90% vs FY2020 ($131.1M, 13%)

How Were They Changing?

Since the FY2021 annual report
Latest quarter: Q2 FY2022, the three months to Jun 30, 2022
Revenue
▲ +11%
vs $280.8M in Q2 FY2021
Net income
▼ 0%
vs $10.2M in Q2 FY2021
  • Oct 3, 2022 Patient Square Capital completed its acquisition of Hanger Hanger became privately held, and its common stock was removed from NYSE trading.
  • Jul 21, 2022 Hanger agreed to be acquired by Patient Square Capital Stockholders were to receive $18.75 per share in cash; closing was expected in the fourth quarter of 2022.

Held flat. Revenue was $1.1B in FY2021, about the same as the $1B of FY2017.

Who Did They Compete With?

Competes with Össur

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support